Quantitative sensory testing and intraepidermal nerve fibre density for improved diagnosis of Fabry disease.

Quantitative sensory testing and intraepidermal nerve fibre density for improved diagnosis of Fabry disease. - SFN assessment for improverd Diagnosis of Fabry disease

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON37662

Enrollment

Registered

2012-09-17

Start date

2013-01-16

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anderson-Fabry disease Fabry disease

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Adult males and females with signs or symptoms possibly attributable to Fabry disease.

Exclusion criteria

Exclusion criteria: Patient is unwilling to participate

Design outcomes

Primary

Measure	Time frame
To determine if alterations of intraepidermal nerve fiber density and quantitative sensory testing are present in patients with a possible diagnosis of Fabry disease, but without clinical signs and symptoms of small fiber neuropathy.	—

Secondary

Measure	Time frame
To evaluate if alterations of intraepidermal nerve fiber density and quantitative sensory testing can contribute to the diagnosis of Fabry disease in patients with a possible diagnosis of Fabry disease, but without clinical signs and symptoms of small fiber neuropathy.	—

Countries

Netherlands

Outcome results